Quoin Pharmaceuticals plans investigator-led studies for QRX009
Go back to Quoin Pharmaceuticals plans investigator-led studies for QRX009| (NASDAQ: QNRX) | Delayed: 3.25 -1.16 (26.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.41 | 52 Week High | $ | |||
| Open | $4.20 | 52 Week Low | $ | |||
| Day High | $5.07 | P/E | N/A | |||
| Day Low | $3.25 | EPS | $ | |||
| Volume | 3,379,029 | |||||

